Cree, Bruce A C <br/><br/>
Efficacy of natalizumab therapy in patients of African descent with relapsing multiple sclerosis: analysis of AFFIRM and SENTINEL data.  [electronic resource] 

 -  Archives of neurology  Apr 2011 
 - 464-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1538-3687 
<br/><br/><label>Standard No.: </label>10.1001/archneurol.2011.45  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Black or African American--ethnology<br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Monoclonal, Humanized<br/>Drug Therapy, Combination--methods<br/>Female<br/>Humans<br/>Interferon beta-1a<br/>Interferon-beta--administration & dosage<br/>Male<br/>Middle Aged<br/>Multiple Sclerosis, Relapsing-Remitting--drug therapy<br/>Natalizumab<br/>Treatment Outcome